# Fahr's Syndrome With Neurocognitive Dysfunction Due to Hypoparathyroidism: A Case Report

**Authors:** Faezeh Sehatpour, Shahrzad Mohseni, Mahnaz Pejman Sani

PMC · DOI: 10.1155/crie/6355371 · 2025-07-15

## TL;DR

A 68-year-old man with hypoparathyroidism showed Fahr's syndrome symptoms, and treatment improved his condition, highlighting the importance of early diagnosis.

## Contribution

This case report highlights hypoparathyroidism as a potential cause of Fahr's syndrome and emphasizes early diagnosis for better outcomes.

## Key findings

- The patient's hypocalcemia and neurological symptoms improved after calcium gluconate treatment.
- Brain imaging showed calcifications in the basal ganglia and thalamic regions consistent with Fahr's syndrome.
- Early identification of hypoparathyroidism can prevent calcification progression and improve prognosis.

## Abstract

Background: Fahr's syndrome is a rare neurodegenerative condition characterized by bilateral progressive calcification of the basal ganglia and other brain structures. Due to overlapping symptoms, it can be misdiagnosed as other neurological disorders.

Case presentation: A 68-year-old man was presented to the emergency department with an exacerbating decline in the level of consciousness and dysarthria over a 20-day period. On admission, the laboratory examinations revealed a low level of calcium and parathyroid hormone. Brain imaging findings showed bilateral calcifications in the basal ganglia, pulvinar region of the thalami, and dentate nuclei. In addition, a prolonged QTc interval on his electrocardiogram (ECG) indicated hypocalcemia. After receiving calcium gluconate 10%, the calcium level and QTc interval stabilized, and the patient's level of consciousness gradually improved.

Conclusion: Fahr's syndrome due to hypoparathyroidism should be suspected in any patient with neurological symptoms and hypocalcemia. Hence, early identification and management of hypoparathyroidism can prevent progression of calcification and improve patients' quality of life and prognosis.

## Linked entities

- **Chemicals:** calcium (PubChem CID 5460341), calcium gluconate (PubChem CID 9290)
- **Diseases:** hypoparathyroidism (MONDO:0001220)

## Full-text entities

- **Genes:** PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}
- **Diseases:** hypocalcemia (MESH:D006996), Hypoparathyroidism (MESH:D007011), Neurocognitive Dysfunction (MESH:D019965), calcification (MESH:D002114), Fahr's Syndrome (MESH:C536275), neurological disorders (MESH:D009461), dysarthria (MESH:D004401), neurodegenerative condition (MESH:D019636)
- **Chemicals:** calcium (MESH:D002118), calcium gluconate (MESH:D002125)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12283200/full.md

---
Source: https://tomesphere.com/paper/PMC12283200